The transgenic rat (TGR) (mRen2)27 was the first hypertensive transgen
ic rat model developed. The model is unique in that it allows studying
the effects of a single gene, namely the mouse salivary gland renin g
ene (mRen2), in the rat. The transgene is expressed in various rat tis
sues, including the central nervous system, adrenal gland, and the kid
ney. TGR exhibit a rightward shifted pressure-natriuresis curve that i
s overwhelmingly angiotensin II (Ang II) dependent. The mRen2 transgen
e, the rat's own renin gene, angiotensinogen, and the type 1 Ang II re
ceptor, AT(1), are all expressed in the kidneys of TGR. The rat's own
renin gene is regulated normally in renal tissue, while the mRen2 tran
sgene operates independently of blood pressure. These results, coupled
with findings that the mRen2 transgene product converts rat angiotens
inogen more effectively than endogenous rat renin, that the TGR may ha
ve high circulating mouse renin levels which increase with age, and th
e fact that high circulating prorenin concentrations are present in th
ese TGR, shed light on the kidney's role in the blood-pressure-elevati
ng mechanisms of TGR. The viewpoint that the kidneys are not mechanist
ically important in this TGR model must be revised.